trial

Personalized Metacognitive Training for Psychosis: A Randomized Controlled Trial

NCTId NCT07146802
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Not Yet Recruiting
Enrollment 51 (estimated)
Sponsored by University Hospital, Strasbourg, France
Primary completion 2027-04-01
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Not Yet Recruiting
Enrollment
51 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2025-10-01
Primary completion
2027-04-01
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Metacognitive Training (MCT) for psychosis

Sponsors

University Hospital, Strasbourg, FranceLead Sponsor

Sites

0 total

Facts & assertions

4 sourced
Enrollment
51
Phase
NA
Primary Completion Date
2027-04-01
Status
NOT_YET_RECRUITING
relationships
The graph out of here
drug
Metacognitive Training (MCT) for psychosis
drug
lead_sponsor
University Hospital, Strasbourg, France
company
indication
Schizophrenia Spectrum Disorder
indication